(Q43758841)

26 November 2017

title

Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus (English)

1 reference

human subject research project

26 November 2017

main subject

0 references

author name string

Abu El-Asrar AM

1

1 reference

26 November 2017

Desmet S

2

1 reference

26 November 2017

Meersschaert A

3

1 reference

26 November 2017

Dralands L

4

1 reference

26 November 2017

Missotten L

5

1 reference

26 November 2017

Geboes K

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

American Journal of Ophthalmology

26 November 2017

published in

1 reference

26 November 2017

volume

132

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

551-556

1 reference

Nitric oxide as a secretory product of mammalian cells

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Inducible nitric oxide synthase: what difference does it make?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Expression of inducible nitric oxide synthase immunoreactivity in rat brain following chronic hypoxia: effect of aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Müller cell changes in human diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Induction and regulation of nitric oxide synthase in retinal Müller glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Requirement for nitric oxide in retinal neuronal cell death induced by activated Müller glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Diabetes, advanced glycation endproducts and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Biological effects of aminoguanidine: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

10.1016/S0002-9394(01)01127-8

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference